Latest Insider Transactions at Ionis Pharmaceuticals Inc (IONS)
This section provides a real-time view of insider transactions for Ionis Pharmaceuticals Inc (IONS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IONIS PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IONIS PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2023
|
Richard S Geary EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,112
-5.34%
|
$201,488
$49.29 P/Share
|
|
Dec 21
2023
|
Richard S Geary EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,112
+5.07%
|
$193,264
$47.34 P/Share
|
|
Dec 21
2023
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
16,113
-19.68%
|
$789,537
$49.29 P/Share
|
|
Dec 21
2023
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,113
+16.45%
|
$757,311
$47.34 P/Share
|
|
Dec 20
2023
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,500
-5.22%
|
$318,500
$49.64 P/Share
|
|
Dec 20
2023
|
Brett P Monia Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+4.96%
|
$305,500
$47.34 P/Share
|
|
Dec 20
2023
|
Richard S Geary EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
6,500
-8.18%
|
$318,500
$49.64 P/Share
|
|
Dec 20
2023
|
Richard S Geary EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+7.56%
|
$305,500
$47.34 P/Share
|
|
Dec 20
2023
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-9.0%
|
$318,500
$49.64 P/Share
|
|
Dec 20
2023
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+8.25%
|
$305,500
$47.34 P/Share
|
|
Dec 14
2023
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
22,612
-14.57%
|
$1,107,988
$49.7 P/Share
|
|
Dec 14
2023
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,612
+12.66%
|
$1,062,764
$47.34 P/Share
|
|
Dec 14
2023
|
Richard S Geary EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,613
-6.76%
|
$520,037
$49.7 P/Share
|
|
Dec 14
2023
|
Richard S Geary EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,613
+6.31%
|
$498,811
$47.34 P/Share
|
|
Dec 14
2023
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,000
-9.18%
|
$1,176,000
$49.7 P/Share
|
|
Dec 14
2023
|
Brett P Monia Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+8.38%
|
$1,128,000
$47.34 P/Share
|
|
Nov 15
2023
|
Joseph Klein Iii Director |
SELL
Open market or private sale
|
Direct |
2,000
-10.9%
|
$100,000
$50.0 P/Share
|
|
Oct 17
2023
|
Eric Swayze EVP Research |
SELL
Open market or private sale
|
Indirect |
52
-41.6%
|
$2,444
$47.95 P/Share
|
|
Oct 16
2023
|
Eric Swayze EVP Research |
BUY
Exercise of conversion of derivative security
|
Indirect |
125
+50.0%
|
-
|
|
Oct 12
2023
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,770
-3.09%
|
$173,420
$46.0 P/Share
|
|
Sep 28
2023
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,460
-6.35%
|
$205,160
$46.5 P/Share
|
|
Sep 26
2023
|
Joseph Klein Iii Director |
SELL
Open market or private sale
|
Direct |
2,000
-9.83%
|
$90,000
$45.13 P/Share
|
|
Sep 26
2023
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
10,000
-10.8%
|
$450,000
$45.13 P/Share
|
|
Aug 31
2023
|
Brett P Monia Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
157
+0.13%
|
$4,710
$30.56 P/Share
|
|
Aug 31
2023
|
Richard S Geary EVP, Chief Development Officer |
BUY
Other acquisition or disposition
|
Direct |
1
+0.0%
|
$30
$30.56 P/Share
|
|
Aug 31
2023
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
180
+0.26%
|
$5,400
$30.56 P/Share
|
|
Aug 01
2023
|
Allene M. Diaz Director |
SELL
Open market or private sale
|
Direct |
657
-4.93%
|
$26,937
$41.05 P/Share
|
|
Jul 18
2023
|
Joseph Klein Iii Director |
SELL
Open market or private sale
|
Direct |
3,555
-14.87%
|
$149,310
$42.0 P/Share
|
|
Jul 17
2023
|
Spencer R Berthelsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,110
+2.37%
|
-
|
|
Jul 17
2023
|
Allene M. Diaz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,333
+28.57%
|
-
|
|
Jul 17
2023
|
Michael R Hayden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,110
+10.83%
|
-
|
|
Jul 17
2023
|
Joan E Herman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,110
+8.88%
|
-
|
|
Jul 17
2023
|
Joseph Klein Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,110
+13.49%
|
-
|
|
Jul 17
2023
|
Joseph Loscalzo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,110
+8.11%
|
-
|
|
Jul 17
2023
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,110
+3.72%
|
-
|
|
Jul 17
2023
|
Joseph H Wender Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,110
+3.09%
|
-
|
|
Jul 07
2023
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,650
-13.29%
|
$783,300
$42.25 P/Share
|
|
Jun 20
2023
|
Spencer R Berthelsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+7.43%
|
$315,000
$28.47 P/Share
|
|
Jun 12
2023
|
Joan E Herman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,555
+10.53%
|
-
|
|
May 24
2023
|
Patrick R. O'Neil EVP CLO & General Counsel |
SELL
Open market or private sale
|
Direct |
1,527
-3.65%
|
$62,607
$41.7 P/Share
|
|
May 22
2023
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,931
-1.71%
|
$197,240
$40.14 P/Share
|
|
Apr 18
2023
|
Joseph Baroldi EVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,880
-26.85%
|
$139,680
$36.5 P/Share
|
|
Apr 18
2023
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
SELL
Open market or private sale
|
Direct |
2,582
-9.6%
|
$92,952
$36.5 P/Share
|
|
Apr 18
2023
|
Brian Birchler EVP, Corp and Development Ops |
SELL
Open market or private sale
|
Direct |
672
-1.81%
|
$24,192
$36.5 P/Share
|
|
Apr 17
2023
|
Joseph Baroldi EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,838
+42.86%
|
-
|
|
Apr 17
2023
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
5,667
+17.4%
|
-
|
|
Apr 17
2023
|
Brian Birchler EVP, Corp and Development Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+4.8%
|
-
|
|
Feb 28
2023
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
383
+0.54%
|
$11,490
$30.52 P/Share
|
|
Feb 28
2023
|
Elizabeth L Hougen EVP, Finance & CFO |
BUY
Other acquisition or disposition
|
Direct |
163
+0.22%
|
$4,890
$30.52 P/Share
|
|
Feb 28
2023
|
Richard S Geary EVP, Chief Development Officer |
BUY
Other acquisition or disposition
|
Direct |
575
+0.78%
|
$17,250
$30.52 P/Share
|